Cyclo Therapeutics, Inc.·4

Apr 24, 10:28 AM ET

FINE N SCOTT 4

4 · Cyclo Therapeutics, Inc. · Filed Apr 24, 2023

Insider Transaction Report

Form 4
Period: 2023-04-20
FINE N SCOTT
Director
Transactions
  • Purchase

    Common Stock

    2023-04-20$0.71/sh+299,402$212,575444,402 total
  • Purchase

    Warrant to Purchase Common Stock

    2023-04-20$0.13/sh+299,402$37,425299,402 total
    Exercise: $0.71From: 2023-04-20Exp: 2030-04-20Common Stock (299,402 underlying)

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4